BRPI0417272B8 - processo para a preparação de (3r, 3as, 6ar)-hexahidrofuro [2,3-b] furan-3-il (1s, 2r)-3-[[(4-aminofenil) sulfonil] (isobutil) amino]-1-benzil-2-hidroxipropilcarbamato - Google Patents

processo para a preparação de (3r, 3as, 6ar)-hexahidrofuro [2,3-b] furan-3-il (1s, 2r)-3-[[(4-aminofenil) sulfonil] (isobutil) amino]-1-benzil-2-hidroxipropilcarbamato

Info

Publication number
BRPI0417272B8
BRPI0417272B8 BRPI0417272A BRPI0417272A BRPI0417272B8 BR PI0417272 B8 BRPI0417272 B8 BR PI0417272B8 BR PI0417272 A BRPI0417272 A BR PI0417272A BR PI0417272 A BRPI0417272 A BR PI0417272A BR PI0417272 B8 BRPI0417272 B8 BR PI0417272B8
Authority
BR
Brazil
Prior art keywords
amino
isobutyl
hydroxypropylcarbamate
hexahydrofuro
aminophenyl
Prior art date
Application number
BRPI0417272A
Other languages
English (en)
Inventor
M Ebert Birgit
Burghard Zinser Hartmut
Martha Felix Goyvaerts Nicolaas
Tom Bert Paul Wigerinck Piet
Original Assignee
Janssen R&D Ireland
Janssen Sciences Ireland Uc
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34740665&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0417272(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen R&D Ireland, Janssen Sciences Ireland Uc, Tibotec Pharm Ltd filed Critical Janssen R&D Ireland
Publication of BRPI0417272A publication Critical patent/BRPI0417272A/pt
Publication of BRPI0417272B1 publication Critical patent/BRPI0417272B1/pt
Publication of BRPI0417272B8 publication Critical patent/BRPI0417272B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

processo para a preparação de (3r,3as,6ar)-hexahidrofuro [2,3-b] furan-3-il (1s,2r)-3-[[(4aminofenil) sulfonil] (isobutil) amino]-1-benzil-2hidroxipropilcarbamato. a presente invenção refere-se a um processo para a preparação de (3r,3as,6ar)hexahidrofuro [2,3-b] furan-3-il (1s,2r)-3-[[(4-aminofenil) sulfonil] (isobutil) amino]-1-benzil-2-hidroxipropilcarbamato bem como intermediários para uso em ditos processos. mais em particular, a invenção relaciona-se a processos para a preparação de (3r,3as,6ar)hexahidrofuro [2,3b] furan-3-il (1s,2r)-3-[[(4-aminofenil) sulfonil] (isobutil) amino ]-1-benzil-2hidroxipropilcarbamato o qual faz uso do intermediário 4-amino-n[(2r,3s)-3amino-2-hidróxi-4-fenilbutil]-n-isobutil)benzeno sulfonamida, e os quais são processos amenáveis a escala industrial. (3r,3as,6ar)hexahidrofuro [2,3-b] furan-3-il (1s,2r)-3-[[(4-aminofenil) sulfonil] (isobutil) amino]-1-benzil-2hidroxipropilcarbamato é particularmente útil como inibidor de hiv-protease.
BRPI0417272A 2003-12-23 2004-12-23 processo para a preparação de (3r, 3as, 6ar)-hexahidrofuro [2,3-b] furan-3-il (1s, 2r)-3-[[(4-aminofenil) sulfonil] (isobutil) amino]-1-benzil-2-hidroxipropilcarbamato BRPI0417272B8 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP03104949 2003-12-23
EP031049497 2003-12-23
US56818304P 2004-05-04 2004-05-04
US60/568,183 2004-05-04
PCT/EP2004/053692 WO2005063770A1 (en) 2003-12-23 2004-12-23 Process for the preparation of (3r,3as,6ar)-hexahydrofuro [2,3-b] furan-3-yl (1s,2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate

Publications (3)

Publication Number Publication Date
BRPI0417272A BRPI0417272A (pt) 2007-03-27
BRPI0417272B1 BRPI0417272B1 (pt) 2020-08-18
BRPI0417272B8 true BRPI0417272B8 (pt) 2021-05-25

Family

ID=34740665

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0417272A BRPI0417272B8 (pt) 2003-12-23 2004-12-23 processo para a preparação de (3r, 3as, 6ar)-hexahidrofuro [2,3-b] furan-3-il (1s, 2r)-3-[[(4-aminofenil) sulfonil] (isobutil) amino]-1-benzil-2-hidroxipropilcarbamato

Country Status (21)

Country Link
EP (1) EP1725566B1 (pt)
KR (1) KR101192859B1 (pt)
CN (1) CN1898248B (pt)
AT (1) ATE433982T1 (pt)
AU (1) AU2004309122B2 (pt)
BR (1) BRPI0417272B8 (pt)
CA (1) CA2549460C (pt)
CY (1) CY1109379T1 (pt)
DE (1) DE602004021640D1 (pt)
DK (1) DK1725566T3 (pt)
ES (1) ES2328701T3 (pt)
HR (1) HRP20090488T1 (pt)
IL (1) IL174960A (pt)
MX (1) MXPA06007211A (pt)
NO (1) NO337636B1 (pt)
PL (1) PL1725566T3 (pt)
PT (1) PT1725566E (pt)
RU (1) RU2376308C2 (pt)
SI (1) SI1725566T1 (pt)
WO (1) WO2005063770A1 (pt)
ZA (1) ZA200605163B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR058238A1 (es) 2005-11-28 2008-01-23 Tibotec Pharm Ltd Compuestos y derivados de aminofenilsulfonamida sustituida como inhibidores de proteasa del vih
ATE497499T1 (de) * 2006-11-09 2011-02-15 Tibotec Pharm Ltd Verfahren zur herstellung von hexahydrofuroä2,3- büfuran-3-ol
JP2010525029A (ja) 2007-04-27 2010-07-22 テイボテク・フアーマシユーチカルズ・リミテツド Ｎ−イソブチル−ｎ−（２−ヒドロキシ−３−アミノ−４−フェニルブチル）−ｐ−ニトロベンゼンスルホニルアミド誘導体の製造方法
WO2009055006A1 (en) * 2007-10-26 2009-04-30 Concert Pharmaceuticals, Inc. Deuterated darunavir
US8592487B2 (en) 2007-10-26 2013-11-26 Concert Pharmaceuticals, Inc. Deuterated darunavir
TWI482775B (zh) * 2008-09-01 2015-05-01 Tibotec Pharm Ltd 用於製備（３ｒ，３ａｓ，６ａｒ）－六氫呋喃并〔２，３－ｂ〕呋喃－３－基（１ｓ，２ｒ）－３－〔〔（４－胺基苯基）磺醯基〕（異丁基）胺基〕－１－苯甲基－２－羥基丙基胺基甲酸酯之方法
US8921415B2 (en) 2009-01-29 2014-12-30 Mapi Pharma Ltd. Polymorphs of darunavir
BRPI1010546B8 (pt) * 2009-05-13 2022-08-23 Meiji Seika Pharma Co Ltd processo para produzir composto, método para isolar e purificar cristais de solvato do composto, e, uso do composto
EP2477992B1 (en) 2009-09-17 2016-12-14 Mylan Laboratories Limited Processes for the preparation of darunavir and the amorphous form thereof
KR20120123077A (ko) 2010-01-05 2012-11-07 씨아이피엘에이 엘티디. 다루나비르 다형체 및 그의 제조 방법
AU2011210349A1 (en) 2010-01-28 2012-07-05 Mapi Pharma Limited Process for the preparation of darunavir and darunavir intermediates
CN102584844B (zh) * 2011-01-11 2016-04-13 浙江九洲药业股份有限公司 一种达芦那韦晶型及其制备方法
EP3795572B1 (en) * 2012-07-24 2023-11-15 Laurus Labs Limited Darunavir propionate solvate
CN103893178B (zh) * 2014-03-19 2016-06-01 中山大学 苯-磺酰胺类化合物在制备抗hiv-1病毒药物中的应用
US20160075643A1 (en) * 2014-09-16 2016-03-17 Zcl Chemicals Limited Novel process to prepare intermediates of hiv-protease inhibitors thereof
WO2016207907A1 (en) * 2015-06-25 2016-12-29 Msn Laboratories Private Limited Process for the preparation of [(1 s,2r)-3-[[(4-aminophenyl)sulfonyl] (2-methylpropyl)amino]-2-hydroxy-1 -(phenylmethyl)propyl]-carbamic acid (3r,3as,6ar)hexahydro furo[2,3-b]furan-3-yl ester and its amorphous form
US10407438B2 (en) 2016-10-27 2019-09-10 Gilead Sciences, Inc. Crystalline forms of darunavir
HUE053006T2 (hu) 2016-11-17 2021-06-28 Janssen Sciences Ireland Unlimited Co Egyszerûsített eljárás darunavir elõállítására
CN118026896A (zh) * 2020-12-30 2024-05-14 上海飞腾医药科技有限公司 抗hiv类药物中间体晶体的生长方法和所得晶体
CN113896658A (zh) * 2021-09-24 2022-01-07 上药康丽（常州）药业有限公司 一种利用微通道反应器合成地瑞那韦中间体的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143747A (en) 1995-01-20 2000-11-07 G. D. Searle & Co. Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
CA2186483A1 (en) 1995-02-03 1996-08-08 Akira Nishiyama Processes for producing .alpha.-halo ketones, .alpha.-halohydrins and epoxides
US5756533A (en) 1995-03-10 1998-05-26 G.D. Searle & Co. Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US6150556A (en) 1995-03-10 2000-11-21 G. D. Dearle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US5705500A (en) 1995-03-10 1998-01-06 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
CZ297676B6 (cs) 1995-03-10 2007-03-07 G. D. Searle & Co. Deriváty hydroxyethylaminosulfonamidu jako inhibitory retrovirové proteázy, farmaceutická kompozice
ATE334121T1 (de) 1999-01-29 2006-08-15 Kaneka Corp Verfahren zur herstellung von threo-1,2-epoxy-3- amino-4-phenylbutan-derivaten
KR20020046948A (ko) 2000-12-12 2002-06-21 에가시라 구니오 에폭사이드 결정의 제조방법
ATE429431T1 (de) 2001-05-11 2009-05-15 Tibotec Pharm Ltd 2-amino-benzoxazol-suphonamide als breitspektrum- hiv-protease-inhibitoren
CA2472133A1 (en) * 2001-12-28 2003-07-17 Ajinomoto Co., Inc. Process for producing crystal of benzenesulfonamide derivative, and novel crystal of intermediate therefor and process for producing the same

Also Published As

Publication number Publication date
CA2549460C (en) 2014-08-05
EP1725566B1 (en) 2009-06-17
AU2004309122B2 (en) 2011-07-21
IL174960A0 (en) 2006-08-20
RU2376308C2 (ru) 2009-12-20
CY1109379T1 (el) 2014-07-02
ATE433982T1 (de) 2009-07-15
MXPA06007211A (es) 2006-08-18
PT1725566E (pt) 2009-09-16
BRPI0417272B1 (pt) 2020-08-18
ES2328701T3 (es) 2009-11-17
DE602004021640D1 (de) 2009-07-30
IL174960A (en) 2011-06-30
CN1898248B (zh) 2011-08-17
KR101192859B1 (ko) 2012-10-19
AU2004309122A1 (en) 2005-07-14
DK1725566T3 (da) 2009-10-05
PL1725566T3 (pl) 2009-11-30
NO337636B1 (no) 2016-05-23
CA2549460A1 (en) 2005-07-14
ZA200605163B (en) 2007-12-27
NO20063401L (no) 2006-07-21
HRP20090488T1 (en) 2009-10-31
RU2006126670A (ru) 2008-01-27
KR20060123740A (ko) 2006-12-04
CN1898248A (zh) 2007-01-17
WO2005063770A1 (en) 2005-07-14
EP1725566A1 (en) 2006-11-29
SI1725566T1 (sl) 2009-12-31
BRPI0417272A (pt) 2007-03-27

Similar Documents

Publication Publication Date Title
NO20063401L (no) Fremgangsmate for fremstillingen av (3R,3AS,6AR)-heksahydrofuro [2,3-B]furan-3-yl (1S,2R)-3-[[(4-aminofenyl)sulfonyl](isobutyl) amino]-1-benzyl-2-hydroksypropylkarbamat
UA85567C2 (en) Process for the preparation of (3r,3as,6ar)-hexahydrofuro [2,3-b] furan-3-yl (1s,2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate
CY1119311T1 (el) Ψευδο-πολυμορφικες μορφες καταστολεα πρωτεασης hiv
BRPI0212341B8 (pt) compostos intermediários de inibidores de protease de hiv e processo para preparação dos mesmos
WO2006076415A3 (en) Exo- and diastereo- selective syntheses of himbacine analogs
BR112012018862A2 (pt) processo para a preparação de darunavir e intermediários de darunavir
BRPI0917377A2 (pt) processo para a preparacao de (1s,2r)-3-[[(4-aminofenil) sulfonil] (isobutil) amino]-1-benzil-2-hidroxipropilcarbamato de (3r,3as,6ar)-hexahidrofuro[2,3-b] furan-3-ila
BRPI0415209A (pt) derivados de tetraidronaftaleno, processo para a produção deles e seu emprego como agentes antiinflamatórios
BRPI0509273B8 (pt) Processo aperfeiçoado para a preparação de n-([1,2,4[triazolpirimidin-2-il)aril sulfonamidas
MX2009004957A (es) Metodos para la preparacion de hexahidrofuro[2,3-b]furan-3-ol.
PA8618901A1 (es) Biaril sulfonamidas y metodo para el uso de las mismas
ATE382604T1 (de) Aminosäure-derivate als hiv aspartyl-protease- inhibitoren
BR112012009956A2 (pt) um novo processo para a preparação de darunavir e etanolato darunavir de tamanho de partícula.
BRPI0408417A (pt) métodos para a produção de um resìduo de gla purificado contendo serina protease, para a purificação de um resìduo de gla contendo serina protease e para estabilização de um resìduo de gla contendo serina protease, e, composição
WO2006102535A3 (en) Sulfonyl containing compounds as cysteine protease inhibitors
EA200600563A1 (ru) Способ получения рензаприда и его промежуточных соединений
NO20061951L (no) Fremgangsmater for fremstillingen av benzoksazol-sulfonamid-forbindelser og intermediater derav
BR0211651A (pt) 3,5-dihidróxi-2,2-dimetil-valeronitrilas protegidas, para a sìntese de epotilonas e derivados e processos para produção e uso
HUP0402491A2 (hu) Eljárás 2-(szubsztituált fenil)-2-hidroxi-etil-karbamátok előállítására
TW200716948A (en) Micro gyroscope
ECSP034515A (es) Proceso para producir compuestos quirales
UA86030C2 (ru) Способ получения соединений бензоксазолсульфонамида (варианты) и промежуточные соединения
FR2883215B1 (fr) Procede d'usinage d'une face de lentille optalmique prismee au centre
UY27102A1 (es) Formas cristalinas
HN2002000062A (es) Derivados espirociclicos nuevos y su uso como inhibidores

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA INT.CL: C07D 493/04, A61P 31/00

Ipc: C07D 493/04 (2011.01)

B25D Requested change of name of applicant approved

Owner name: TIBOTEC PHARMACEUTICALS (IE)

B25D Requested change of name of applicant approved

Owner name: JANSSEN R AND D IRELAND (IE)

B25A Requested transfer of rights approved

Owner name: JANSSEN SCIENCES IRELAND UC (IE)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.21 NA RPI NO 2552 DE 03/12/2019 POR TER SIDO INDEVIDA.

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 18/08/2020, OBSERVADAS AS CONDICOES LEGAIS.

B17A Notification of administrative nullity (patentee has 60 days time to reply to this notification)

Free format text: REQUERENTE DA NULIDADE: BLANVER FARMOQUIMICA E FARMACEUTICA S/A - 870210015582 - 17/02/2021

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/12/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF